To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Scheuermann's disease
Scheuermann’s disease is a self-limiting skeletal disorder of childhood. Product highlightScheuermann's disease is considered a form of juvenile osteochondrosis of the spine. It is found mostly in teenagers and presents a significantly worse deformity than postural kyphosis. Patients suffering with Scheuermann’s kyphosis cannot consciously correct their posture. The apex of their curve, located in the thoracic vertebrae, is quite rigid. The sufferer may feel pain at this apex, which can be aggravated by physical activity and by long periods of standing or sitting; this can have a significantly detrimental affect to their lives as their level of activity is curbed by their condition and they may feel isolated or uneasy amongst their peers if they are children, depending on the level of deformity. Whereas in postural kyphosis the vertebrae and disks appear normal, in Scheuermann’s kyphosis they are irregular, often herniated, and wedge shaped over at least three adjacent levels. The seventh and tenth thoracic vertebrae are most commonly affected. It causes backache and spinal curvature. In very serious cases it may cause internal problems and spinal cord damage. It is also known as Scheuermann’s kyphosis, since it results in kyphosis. References
|
||||||||||||
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Scheuermann's_disease". A list of authors is available in Wikipedia. |
- Recyclates: Recycled Materials as the Next Step Towards Increased Sustainability for High-End Laboratory Consumables - Disposable racks made from contact lens production leftovers
- Researchers create human airway stem cells from patients' cells - Advancing regenerative research for lung diseases, results could lead to new treatments for airways and lungs damaged by COVID-19, influenza, asthma and cystic fibrosis
- CureVac’s Second-Generation Vaccine Candidate Demonstrates Improved Immune Response and Protection - The optimized mRNA backbone has the potential for a multivalent or combination approach to address multiple emerging variants in one vaccine